2,199 reports of this reaction
1.4% of all ESTRADIOL reports
#19 most reported adverse reaction
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #19 most commonly reported adverse reaction for ESTRADIOL, manufactured by Allergan, Inc.. There are 2,199 FDA adverse event reports linking ESTRADIOL to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 1.4% of all 159,657 adverse event reports for this drug.
Patients taking ESTRADIOL who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is a less commonly reported adverse event for ESTRADIOL, but still significant enough to appear in the safety profile.
In addition to wrong technique in product usage process, the following adverse reactions have been reported for ESTRADIOL:
The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 2,199 FDA reports for ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 1.4% of all adverse event reports for ESTRADIOL, making it a notable side effect.
If you experience wrong technique in product usage process while taking ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.